Riskpilot← Back to searchSign inGet full accessMedTrace Pharma A/S
A/SActiveCVR 36497661Agern Alle 5ARental and leasing of other machinery, equipment and tangible goods n.e.c. · NACE 7739Est. 201535 employeeswww.medtrace.dk
Revenue 2024
DKK 2,3M
-12% vs 2023
EBITDA margin
-1007.4%
-17% vs 2023
Equity ratio
93.3%
Financial strength
Net profit 2024
DKK -15,4M
-2% vs 2023
| Revenue | DKK 2,3M | -12% |
| EBITDA | DKK -23,5M | -17% |
| Net profit | DKK -15,4M | -2% |
| Total assets | DKK 289,6M | -6% |
| Equity | DKK 270,1M | -5% |
| Employees | 35 | — |
Legal name
MedTrace Pharma A/S
CVR number
36497661
Legal form
Aktieselskab
NACE code
7739 · Rental and leasing of other machinery, equipment and tangible goods n.e.c.
Founded
5. januar 2015
Share capital
DKK 12.034.994
Employees
35 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af direktionen i forening, bestyrelsesformanden i forening med én direktør, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle, kommercialisere og sælge et automatisk injektionssystem til radioaktivt vand.
Address
Agern Alle 5A
Phone
+4531388581
Email
connect@medtrace.dk
Website
www.medtrace.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -232.409 | 1.519 | -2.167 | -68 | 1.061 | 3.012 | 1.529 | 2.193 | 2.645 | 2.334 |
| Staff expenses | -80.183 | -173 | -69 | -582 | -783 | -951 | -0 | -0 | -0 | -0 |
| EBITDA | -312.592 | 1.347 | -2.236 | -650 | 278 | 2.061 | -24.475 | -49.052 | -20.072 | -23.515 |
| Depreciation & amort. | -0 | -0 | -7 | -13 | -67 | -237 | -0 | -0 | -0 | -0 |
| EBIT | -312.592 | 1.347 | -2.243 | -663 | 211 | 1.824 | -24.475 | -49.052 | -20.072 | -23.515 |
| Net financials | -2.133 | -56 | -665 | -299 | -1.565 | -962 | -404 | -903 | 1.914 | 2.709 |
| Profit before tax | -314.725 | 1.290 | -2.908 | -963 | -1.354 | 862 | -24.878 | -49.955 | -18.157 | -20.806 |
| Tax | -69.239 | 133 | -906 | 274 | -352 | -383 | -7.027 | -12.919 | -3.051 | -5.450 |
| Net profit | -245.485 | 1.157 | -2.003 | -1.237 | -1.002 | 1.244 | -17.852 | -37.035 | -15.107 | -15.356 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.082.716 | 10.580 | 15.269 | 25.216 | 37.009 | 58.520 | 119.516 | 190.685 | 307.595 | 289.595 |
| Equity | 2.754.628 | 4.157 | 2.441 | 6.737 | 5.735 | 34.617 | 93.707 | 161.191 | 285.237 | 270.065 |
| Long-term debt | 250.000 | 5.178 | 9.870 | 13.394 | 22.883 | 10.324 | 10.622 | 9.869 | 7.126 | 4.395 |
| Short-term debt | 78.088 | 1.244 | 1.247 | 1.416 | 3.130 | 6.778 | 15.187 | 19.625 | 15.232 | 15.135 |
| Total debt | 328.088 | 6.423 | 11.117 | 14.810 | 26.013 | 17.102 | 25.809 | 29.494 | 22.358 | 19.530 |
EBITDA margin
-1007.4%
This company
15.8%
Market median
-6476% vs market
20152024
Equity ratio
93.3%
This company
38.2%
Market median
+144% vs market
20152024
Return on equity
-5.7%
This company
18.4%
Market median
-131% vs market
20152024
Net profit margin
-657.8%
This company
8.1%
Market median
-8221% vs market
20152024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20152024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-05 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MD Founder | Founder | 2015 | — | — |
PL Management | Management | 2015 | — | — |
PJ Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
RW Management | Management | 2021 | — | — |
LR Management | Management | 2025 | — | — |
LT Management | Management | 2024 | — | — |
AK Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2015 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Arbejdsmarkedets Tillægspension | Company | 25.0% | 25.0% | 2023 |
MedTravest IV ApS | Company | 10.0% | 10.0% | 2025 |
| Individual | 10.0% | 10.0% | 2023 | |
Kapitalforeningen BankInvest Select | Company | 5.0% | 5.0% | 2025 |
| Individual | 5.0% | 5.0% | 2025 | |
WASABI-LINK Holding ApS | Company | 5.0% | 5.0% | 2021 |
Styrelsen for Forskning og Uddannelse | Company | 20.0% | 20.0% | 2015 |
| Individual | 5.0% | 5.0% | 2021 | |
Uddannelses- og Forskningsstyrelsen | Company | 5.0% | 5.0% | 2021 |
FONDEN FOR SYDDANSK VÆKSTFREMME | Company | 5.0% | 5.0% | 2023 |
MedTravest A/S | Company | 5.0% | 5.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arbejdsmarkedets Tillægspension
MedTrace Pharma A/S Board members of MedTrace Pharma A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Dal Stenfeldt | Founder | 0 companies |
| Peter Larsen | Management | 0 companies |
| Peter Juul Kristensen | Chief Executive Officer | 0 companies |
| Rune Wiik Kristensen | Management | 0 companies |
| Lykke Rømer | Management | 0 companies |
| Lars Trolle | Management | 0 companies |
| Ann Kristin Brøgger Led | Chief Executive Officer | 0 companies |
| Mads Spangaard Rasmussen | Board of Directors | 0 companies |
| Lenna Maria Boe Broberg | Board of Directors | 0 companies |
| Cesare Orlandi | Board of Directors | 0 companies |
| Bernt Skov Jensen | Board of Directors | 0 companies |
| Bjarne Henning Jensen | Chairman | 0 companies |
| Robert Karl Schier | Board of Directors | 0 companies |
| Ellen Rietmann Ahl | Board of Directors | 0 companies |
| Michael Frank | Board of Directors | 0 companies |
| Jens Hesthaven Sørensen | Board of Directors | 0 companies |
| Claus Henrik Berner Møller | Board of Directors | 0 companies |
| Erik Anders Strömqvist | Chairman | 0 companies |
| Charlotte Vindfeldt | Board of Directors | 0 companies |
| Ulrik Spork | Chairman | 0 companies |